Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP

NCT04794296

Conditions: Childhood ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: CHU de Treichville à ABIDJAN Abidjan, Côte d’Ivoire

CHU Donka 030 BP 554 Conakry, Guinea

Hôpital Aristide Le Dantec, Avenue Pasteur, Dakar, Senegal

View Trial Details

Recruiting

Recommendations for the Treatment of Children With Burkitt's Lymphoma

NCT04425421

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +14 more
Locations: Hopital Yalgado Ouedraogo Ouagadougou, Burkina Faso

CHU de Treichville à ABIDJAN Abidjan, Côte d’Ivoire

Cliniques Universitaires de Kinshasa Kinshasa, Kinshasa City, Democratic Republic of the Congo

Cliniques Universitaires de Lubumbashi (CUL) Lubumbashi, Democratic Republic of the Congo

View Trial Details

Recruiting

Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

NCT07078929

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
Locations: Siriraj Hospital Bangkok, Bangkoknoi, Thailand

Maharaj Nakorn Chiang Mai Hospital Chiang Mai, Mueang Chiang Mai District, Thailand

King Chulalongkorn Memorial Hospital Bangkok, Pathumwan, Thailand

View Trial Details

Recruiting

Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL

NCT06481241

Conditions: Acute Lymphoblastic Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

NCT06481228

Conditions: Acute Lymphoblastic Leukemia, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Recruiting

5HTP Regulation Of Asthma In Children

NCT04160910

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Indiana University Indianapolis, Indiana, United States

View Trial Details

Recruiting

Safety and Efficacy Study of BAFF-R CAR-T Cells in Adult Subjects With CD19-Negative Relapsed or Refractory B-Cell Lymphoma

NCT07369492

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Suzhou Hongci Hematology Hospital Suzhou, China

View Trial Details

Recruiting

Pharmacokinetics of Dexamethasone in Childhood ALL and Reduction in Bone Mineral Density

NCT06367725

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Department of Paediatrics and Adolescent Medicine, Aalborg University Hospital Aalborg, Denmark

Department of Paediatrics and Adolescent Medicine, Aarhus University Hospital Aarhus N, Denmark

Department of Paediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet Copenhagen, København Ø, Denmark

Department of Paediatrics and Adolescent Medicine, Odense University Hospital Odense, Odense C, Denmark

View Trial Details

Recruiting

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

NCT06151730

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)

NCT06504940

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: The First Affiliated Hospital ，Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions